✦ LIBER ✦

Clinical-Pharmacological Strategies to Assess Drug Interaction Potential During Drug Development

✍ Scribed by Professor Jochen Kuhlmann, Wolfgang Mück

Book ID: 119925253
Publisher: Springer International Publishing AG
Year: 2001
Tongue: English
Weight: 152 KB
Volume: 24
Category: Article
ISSN: 0114-5916
DOI: 10.2165/00002018-200124100-00001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Optimizing drug development: Strategies

Optimizing drug development: Strategies to assess drug metabolism/transporter interaction potential-toward a consensus

✍ Tucker, G 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 127 KB

Optimising drug development: strategies

Optimising drug development: strategies to assess drug metabolism/transporter interaction potential — towards a consensus

📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 222 KB

Optimizing Drug Development: Strategies

Optimizing Drug Development: Strategies to Assess Drug Metabolism/Transporter Interaction Potential—Toward a Consensus

✍ Geoffrey T. Tucker; J. Brian Houston; Shiew-Mei Huang 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 169 KB

AAPS Workshop Report: Strategies to Addr

AAPS Workshop Report: Strategies to Address Therapeutic Protein–Drug Interactions during Clinical Development

✍ Sandhya Girish; Steven W Martin; Mark C Peterson; Lei K. Zhang; Hong Zhao; Josep 📂 Article 📅 2011 🏛 American Association of Pharmaceutical Scientists 🌐 English ⚖ 464 KB

Population pharmacokinetic modelling to

Population pharmacokinetic modelling to assess clinical drug-drug interaction between AZD7325 and midazolam

✍ Zhou, D.; Lu, Z.; Sunzel, M.; Xu, H.; Al-Huniti, N. 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 624 KB

Assessing Psychiatric Adverse Effects du

Assessing Psychiatric Adverse Effects during Clinical Drug Development

✍ Rudorfer, Matthew V.; Hillefors, Mi 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 353 KB